[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU6150200A - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
AU6150200A
AU6150200A AU61502/00A AU6150200A AU6150200A AU 6150200 A AU6150200 A AU 6150200A AU 61502/00 A AU61502/00 A AU 61502/00A AU 6150200 A AU6150200 A AU 6150200A AU 6150200 A AU6150200 A AU 6150200A
Authority
AU
Australia
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61502/00A
Inventor
Ian Charles Kilpatrick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Publication of AU6150200A publication Critical patent/AU6150200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Addiction (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU61502/00A 1999-06-24 2000-06-16 Therapeutic agents Abandoned AU6150200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914743.1A GB9914743D0 (en) 1999-06-24 1999-06-24 Therapeutic agents
GB9914743 1999-06-24
PCT/EP2000/005543 WO2001000186A2 (en) 1999-06-24 2000-06-16 New use of 1,2,4-triazolo'1,5-a! pyrimidines

Publications (1)

Publication Number Publication Date
AU6150200A true AU6150200A (en) 2001-01-31

Family

ID=10855954

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61502/00A Abandoned AU6150200A (en) 1999-06-24 2000-06-16 Therapeutic agents

Country Status (7)

Country Link
EP (1) EP1218008A2 (en)
JP (1) JP2003503343A (en)
AU (1) AU6150200A (en)
CA (1) CA2376886A1 (en)
GB (1) GB9914743D0 (en)
MX (1) MXPA01013421A (en)
WO (1) WO2001000186A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010056631A1 (en) 2008-11-12 2010-05-20 Schering Corporation Inhibitors of fatty acid binding protein (fabp)
WO2011043994A1 (en) 2009-10-08 2011-04-14 Schering Corporation Inhibitors of fatty acid binding protein (fabp)
KR101775682B1 (en) 2015-11-30 2017-09-06 주식회사 대웅 Methods for Preparing Botulinum Toxin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321162D0 (en) * 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents
GB9906126D0 (en) * 1999-03-18 1999-05-12 Knoll Ag Pharmaceutical formulations
GB9906130D0 (en) * 1999-03-18 1999-05-12 Knoll Ag Compounds for use in therapy
GB9906124D0 (en) * 1999-03-18 1999-05-12 Knoll Ag Therapeutic agent

Also Published As

Publication number Publication date
EP1218008A2 (en) 2002-07-03
MXPA01013421A (en) 2002-07-30
GB9914743D0 (en) 1999-08-25
CA2376886A1 (en) 2001-01-04
WO2001000186A3 (en) 2002-05-10
WO2001000186A2 (en) 2001-01-04
JP2003503343A (en) 2003-01-28

Similar Documents

Publication Publication Date Title
AU2001252135A1 (en) Therapeutic agents
EP1212327B8 (en) Pyrazolopyrimidines as therapeutic agents
HK1200316A1 (en) Therapeutic microfoams
GB9911863D0 (en) Therapeutic agents
GB9905010D0 (en) Therapeutic agents
AU5259100A (en) Medicament
IL150030A0 (en) Therapeutic agents
GB9904786D0 (en) Therapeutic agents
GB9929685D0 (en) Therapeutic agents
GB9929687D0 (en) Therapeutic agents
GB9911881D0 (en) Therapeutic agents
GB9921351D0 (en) Therapeutic agents
AU2451500A (en) Therapeutic agents
GB9929569D0 (en) Therapeutic agents
GB9914744D0 (en) Therapeutic agents
AU2001273903A1 (en) Therapeutic agents
GB9903119D0 (en) Therapeutic agents
AU5973600A (en) Therapeutic agents
GB9914742D0 (en) Therapeutic agents
GB9902881D0 (en) Therapeutic agents
AU2001275696A1 (en) Therapeutic agent
AU6150200A (en) Therapeutic agents
AU5817400A (en) Therapeutic agents
AU5817500A (en) Therapeutic agents
AU6302300A (en) Therapeutic agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase